{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Skeletal+Scintigraphy&page=2", "query": { "intervention": "Skeletal Scintigraphy", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Skeletal+Scintigraphy&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T10:54:47.265Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06508021", "title": "A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Fibrodysplasia Ossificans Progressiva" ], "interventions": [ { "name": "Andecaliximab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ashibio Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 92, "start_date": "2024-10-25", "completion_date": "2029-02-04", "has_results": false, "last_update_posted_date": "2025-10-14", "last_synced_at": "2026-09-26T10:54:47.265Z", "location_count": 3, "location_summary": "San Francisco, California • Rochester, Minnesota • Philadelphia, Pennsylvania", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06508021" }, { "nct_id": "NCT03697577", "title": "CDK and Body Composition Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "CT scans", "type": "DIAGNOSTIC_TEST" }, { "name": "DEXA scan", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2019-01-08", "completion_date": "2026-07-08", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-26T10:54:47.265Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03697577" }, { "nct_id": "NCT00375830", "title": "Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "Bone scan", "type": "PROCEDURE" }, { "name": "99mTc-methyl diphosphonate", "type": "DRUG" }, { "name": "Positron Emission Tomography (PET) scan", "type": "PROCEDURE" }, { "name": "18F-Fludeoxyglucose (18F-FDG)", "type": "DRUG" }, { "name": "Computed Tomography (CT) scan", "type": "PROCEDURE" }, { "name": "18F-Sodium Fluoride (18F-NaF)", "type": "DRUG" }, { "name": "Whole Body Magnetic Resonance Imaging (WB-MRI) scan", "type": "PROCEDURE" }, { "name": "Gadopentetate dimeglumine", "type": "DRUG" }, { "name": "Gadofosveset", "type": "DRUG" }, { "name": "Gadobutrol", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 114, "start_date": "2006-01", "completion_date": "2019-03-14", "has_results": true, "last_update_posted_date": "2023-12-12", "last_synced_at": "2026-09-26T10:54:47.265Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00375830" }, { "nct_id": "NCT03784911", "title": "Body Composition During Cancer Treatment", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cancer" ], "interventions": [ { "name": "SOZO Device", "type": "DEVICE" }, { "name": "DEXA Scan", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Prisma Health-Upstate", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 51, "start_date": "2018-10-01", "completion_date": "2023-11-15", "has_results": false, "last_update_posted_date": "2024-10-28", "last_synced_at": "2026-09-26T10:54:47.265Z", "location_count": 1, "location_summary": "Greenville, South Carolina", "locations": [ { "city": "Greenville", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03784911" }, { "nct_id": "NCT06179888", "title": "Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Iberdomide", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Patient Monitoring", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Skeletal Survey X-Ray", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 84, "start_date": "2024-08-27", "completion_date": "2027-10-31", "has_results": false, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-09-26T10:54:47.265Z", "location_count": 74, "location_summary": "Irvine, California • Los Angeles, California • Orange, California + 55 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06179888" }, { "nct_id": "NCT02966665", "title": ": Vascular Function in Health and Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Pulmonary Artery Hypertension", "Heart Failure", "Hypertension" ], "interventions": [ { "name": "Maximum Exercise Tests", "type": "OTHER" }, { "name": "BH4, L-NMMA, Vitamin C, Vitamin E, α-Lipoic Acid and L-Ascorbate", "type": "DRUG" }, { "name": "BQ-123", "type": "DRUG" }, { "name": "Fexofenadine, Ranitidine", "type": "DRUG" }, { "name": "Angiotensin-II, Valsartan", "type": "OTHER" }, { "name": "Acetylcholine, Sodium Nitroprusside, Angiotensin-II, Norepinephrine, Phentolamine", "type": "DRUG" }, { "name": "BQ-123, MitoQ, BH4", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "D. Walter Wray", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 420, "start_date": "2008-09", "completion_date": "2030-08", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-26T10:54:47.265Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02966665" }, { "nct_id": "NCT02865434", "title": "Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "Tc99m-tilmanocept", "type": "DRUG" }, { "name": "SPECT Imaging (60 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "SPECT Imaging (180 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (15 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (60 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (180 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (18-20 Hours post-injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (15 Mins Before Injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (after injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (15 minutes post injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (60 minutes post injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (180 minutes post injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (18-20 hours post injection)", "type": "PROCEDURE" }, { "name": "Planar Image with both Hands in Field of View", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Navidea Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2017-01", "completion_date": "2018-06", "has_results": true, "last_update_posted_date": "2021-08-12", "last_synced_at": "2026-09-26T10:54:47.265Z", "location_count": 1, "location_summary": "Kettering, Ohio", "locations": [ { "city": "Kettering", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02865434" }, { "nct_id": "NCT01148121", "title": "Assessment of Bone Density and Bone Turnover Markers in Patients With Down Syndrome and Comparison to the Ts65Dn Model", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Down Syndrome" ], "interventions": [ { "name": "Skeletal Status Assessment of a Down Syndrome Population", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2010-06", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2016-12-07", "last_synced_at": "2026-09-26T10:54:47.265Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01148121" }, { "nct_id": "NCT02839460", "title": "A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sarcopenia" ], "interventions": [ { "name": "Outpatient Muscle Biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 30, "start_date": "2016-11", "completion_date": "2019-03", "has_results": false, "last_update_posted_date": "2019-04-11", "last_synced_at": "2026-09-26T10:54:47.265Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02839460" }, { "nct_id": "NCT05823740", "title": "Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer", "Malignant Neoplasm" ], "interventions": [ { "name": "Bioelectrical impedance Analysis (BIA)", "type": "OTHER" }, { "name": "D3-Creatine Dilution (D3Cr)", "type": "OTHER" }, { "name": "6-Minute Walk Test (6MWT)", "type": "OTHER" }, { "name": "Timed Up and Go (TUG)", "type": "OTHER" }, { "name": "30-second Sit-to-Stand (STS)", "type": "OTHER" }, { "name": "Hand Grip Strength (GS)", "type": "OTHER" }, { "name": "PBTL p16 expression", "type": "OTHER" }, { "name": "CT, MR and PET Imaging", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "8 Years to 21 Years" }, "enrollment_count": 28, "start_date": "2023-05-01", "completion_date": "2026-02-21", "has_results": false, "last_update_posted_date": "2026-05-01", "last_synced_at": "2026-09-26T10:54:47.265Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05823740" } ] }